Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers, a leading medical technology company, announced a partnership to integrate Subtle Medical’s SubtleMR™ image-enhancement software into the MRI machines of Siemens Healthineers. SubtleMR™ will be incorporated into the planned reconstruction pipeline of Siemens Healthineers, Open Recon. SubtleMR is designed to offer DL (deep learning) post-processing for denoising and increased sharpness for the majority of MRI sequences.
Also Raed: Canon Medical Reinforces Commitment to AI Innovation With New Altivity Brand
The planned Open Recon interface of Siemens Healthineers is designed to enable third party image reconstruction and post-processing solutions to be directly integrated in the reconstruction pipeline. This way, no additional image export step is necessary, and the results are directly available on the scanner console. The reconstruction including post-processing with SubtleMR is planned to be selectable in the user interface.
“We are proud to become the first AI technology company Siemens Healthineers has entrusted for their innovative new Open Recon interface,” said Dr. Ajit Shankaranarayanan, Chief Product Officer at Subtle Medical. “This milestone marks how powerful collaborations are between AI innovators and scanner manufacturers in order to provide the most robust imaging solutions to providers and the best care possible to patients worldwide.”
Healthcare systems have long aspired to be patient-centric, and patients have evolved their sense of what a positive experience should be. Artificial intelligence has proven to be a promising tool to enable improved patient comfort with faster imaging exams along with higher quality imaging to support more timely and accurate diagnosis. Subtle Medical’s deep learning-powered SubtleMR™ improves the image quality of accelerated MRI scans, enabling both a better patient experience and more efficient MRI program. The technology is generalizable for the majority of body parts and sequences. Both companies are looking forward to the new partnership.